Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 MAY 4 ... and nanotechnology for drug targeting and controlled release. Cholesteryl-succinyl didanosine (CSD) and cholesteryl-adipoyl didanosine (CAD) ...
2009 AUG 24 ... (15, 40, or 100 mg/kg of body weight/day) by oral gavage during a period of 8 weeks. Didanosine (100 mg/kg/day) was used as a positive control for mitochondrial toxicity. mtDNA levels ...
2009 APR 13 ... classification system (BCS). The drugs selected were zidovudine, propranolol HCl, didanosine, and enalapril maleate. Permeability values from our in vitro diffusion model were ...
2009 AUG 10 ... nelfinavir, efavirenz, nevirapine, stavudine (d4T), zidovudine (ZDV), lamivudine (3TC), didanosine, and abacavir. Skinfolds and circumferences were measured at baseline and every 4 ...
2009 JUN 29 ... over a period of 18-24 months; 3 of the patients were receiving tenofovir and didanosine, which may have contributed to this decrease. There was no evidence of HIV replication, ...
2009 SEP 21 ... natural killer cell function in treatment-experienced adults receiving tenofovir plus didanosine as nucleoside reverse transcription inhibitor backbone,' is newly published data in ...
2009 JUN 29 ... existence of systemic interaction between tenofovir (TFV) disoproxil fumarate (TDF) and didanosine as well as between TDF and lopinavir-ritonavir (LPV/r). Here we investigated TDF ...
2009 JUL 13 ... 0.62, 95% CI 0.48 to 0.80, P< 0.001). This was however largely driven by tenofovir/didanosine being significantly associated with treatment failure (RH 6.48, 95% CI 3.81 to 11.0, ...
2009 MAY 4 ... synthesis and encapsulation into PEGylated nanocarriers was proposed and applied to didanosine, a nucleosidic analogue used to treat HIV-1 associated dementia. In this study, ...
2009 MAY 4 ... whole antiserum) has been constructed for the assay of anti-HIV agent dideoxyinosine (didanosine, DDI). The amperometric immunosensor was reliably used for dideoxyinosine assay in the ...
2009 MAY 11 ... and wild-type (WT) littermate mice with or without TDF (5 weeks). A parallel study used didanosine (ddI) instead of TDF. At termination, heart, kidney, and liver samples were retrieved. ...
2009 AUG 3 ... up until March 2002 when he died of acute pancreatitis related to a drug interaction of didanosine and tenofovir." Yoganathan and colleagues published their study in ...
2009 AUG 10 ... dysfunction. Rats (n = 8) were gavaged daily with 100 mg.kg(-1).d(-1) of tenofovir DF or didanosine. Kidneys and livers were examined after 8 weeks of treatment. The tenofovir group had ...
2009 APR 6 ... "They had mild liver fibrosis and normal liver function tests. All had received didanosine for long periods," wrote E. Vispo and colleagues.
The researchers ...
2009 JUN 15 ... phenotypic susceptibility to at least one drug (one had partial susceptibility to didanosine, one had nevirapine resistance, and eight had resistance or partial susceptibility to at ...
2009 SEP 7 ... pathogenesis includes prolonged exposure to antiretroviral therapy, particularly didanosine." "We performed a nested case-control study including 15 patients with ...
2009 MAY 4 ... The researchers concluded: "The striking resemblance between didanosine (ddI) and 22o may explain the potent anti-HIV activity."
Diazrodriguez ...
